Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

134.58 +0.58 (+0.43%)
Streaming Delayed Price Updated: 12:28 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
44 45 Next >
Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market... 
Via Benzinga
ABBOTT LABORATORIES INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Benzinga Before The Bell: Tesla's Cybertruck Update, Twitter's New Feature, Netflix's Ad-Tier And Other Top Financial Stories Thursday, June 23
CNBC Pilot Shortage Pushes American Airlines To Quit Services In 4 Cities 
Via Benzinga
Abbott Restarts Baby Formula Plant
Abbott shut-down its Sturgis, MI, plant in February as the Food and Drug Administration investigated the deaths of two infants who succumbed to bacterial infections. 
Via Talk Markets
FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens
Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at... 
Via Benzinga
What It Means For US Stocks To Be In A Bear Market
Wall Street has officially fallen into a bear market as investor sentiment is hammered by soaring inflation, rising interest rates and worries about a looming recession in the... 
Via Benzinga
Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16
Wall Street Journal Moderna Plans COVID-19 Vaccine Trial For Infants 
Via Benzinga
More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant
Via Benzinga
As Health Problems Mount Patients Welcome New Treatments
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – There are several serious health problems facing society today. Some, like heart disease, gastrointestinal diseases, cancer,... 
Via FinancialNewsMedia
3 Dividend Stocks to Buy Now for 20 Years of Income Growth
Investors looking for passive income from holding stocks should consider these dividend stocks that offer strong payouts. 
Via InvestorPlace
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. 
Via InvestorPlace
7 Monkeypox Stocks That May Take Off in Q2
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. 
Via InvestorPlace
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,900 Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.54% on an annualized basis producing an average annual return of 14.5%. Currently, Abbott Laboratories has a... 
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.48% since its last report. The company recently reported that it has 13.46 million shares sold short, which is... 
Via Benzinga
5 Analysts Have This to Say About Abbott Laboratories
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
SOBRsafe CEO Reports Boosting Holdings In Company
Photo by Vinicius "amnx" Amano on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Dave Gandini is... 
Via Benzinga
Abbott Stock Looks To Emerge From Bear Market Stronger
Abbott stock also has a 92 Composite Rating, placing it in the top 8% for a group of five key ratings, including EPS. 
Via Investor's Business Daily
Australia, New Zealand Express Support To Address USA Baby Food Crisis
Australia is in talks with the U.S. to supply baby food, Reuters reports. 
Via Benzinga
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.65% on an annualized basis producing an average annual return of 14.68%. Currently, Abbott Laboratories has a... 
Via Benzinga
Quant Ratings Updated on 75 Stocks
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace
Lawmakers Seek Answers From FDA, Abbott On Nationwide Baby Formula Shortage
FDA officials appeared before a congressional panel to answer questions about the crisis after Abbott Laboratories (NYSE: ABT) recalled some baby formula products and closed its manufacturing plant in... 
Via Benzinga
FDA Allows Import Of 2M Baby Formula Cans Amid Supply Shortage: Reuters
The FDA is easing regulations to allow infant formula imports from Britain, bringing around 2 million cans onto empty shelves by June to ease a nationwide shortage, Reuters... 
Via Benzinga
Could This Technology Help Drastically Lower America's Alcohol Abuse In Workplaces?
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Of the 10 common addictions in the U.S., alcohol ranks... 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, May 25
Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims 
Via Benzinga
More Companies Join Race To Ease US Baby Formula Supply Crunch
Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide... 
Via Benzinga
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
One analyst called the rumored deal "transformative," but says the timing is unfavorable. 
Via Investor's Business Daily
Baby Formula From Europe Arrives In US: Enough For 9,000 Babies For A Week
The first shipment of baby formula from Europe arrived by military aircraft in Indiana on Sunday. 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.